Coronavirus (COVID-19) Vaccinations

Our international COVID-19 vaccination dataset is updated each morning (London time), with data up to the previous day. Last update: a year ago.
Reuse our work freelyCite this research

Our vaccination dataset uses the most recent official numbers from governments and health ministries worldwide. Population estimates for per-capita metrics are based on the United Nations World Population Prospects. Income groups are based on the World Bank classification. A full list of our country-specific sources is available at the bottom of this page, and we also answer frequently-asked questions there.

COVID-19 Data Explorer
Download the complete Our World in Data COVID-19 dataset.
Metric
Vaccine doses
Interval
7-day rolling average
Relative to Population
Color by test positivity
Sort by
Country name
Clear selection

Open the Data Explorer in a new tab. Select a group of countries at once: all European countries, 30 largest countries; European Union; Americas; OECD.


The Our World in Data COVID vaccination data

To bring this pandemic to an end, a large share of the world needs to be immune to the virus. The safest way to achieve this is with a vaccine. Vaccines are a technology that humanity has often relied on in the past to bring down the death toll of infectious diseases.

Within less than 12 months after the beginning of the pandemic, several research teams rose to the challenge and developed vaccines that protect from SARS-CoV-2.

Now the challenge is to make these vaccines available to people around the world. It will be key that people in all countries — not just in rich countries — receive the required protection. To track this effort we at Our World in Data are building the international vaccination dataset that we make available on this page. It is updated each morning, with the most recent official numbers up to the previous day.

  • Open access: as with all of our data, we are making this dataset openly available, so that everyone can check and use the data that we bring together. You find the vaccination data in our daily-updated repository on GitHub.
Our work belongs to everyone
Cite our vaccination data
Mathieu, E., Ritchie, H., Ortiz-Ospina, E. et al. A global database of COVID-19 vaccinations. Nat Hum Behav (2021)

Select countries to show in all charts

This page has a number of charts on vaccination. In the box below you can select any country you are interested in — or several if you want to compare countries. All charts on this page will then show data for the countries that you selected.

Add a country to all charts...
Brazil

What share of the population has received at least one dose, and completed the initial vaccination protocol?

The following charts show the breakdown of people vaccinated, between those who have received only their first vaccine dose, and those who have completed the initial vaccination protocol (2 doses for most vaccines, 1 or 3 for a few manufacturers).

How many vaccine doses have been administered in total?

The following map and chart show the number of vaccine doses administered per 100 people within a given population. All doses, including boosters, are counted individually.

How many vaccine doses have been administered in the last 12 months?

The following chart shows, for each date, the total number of vaccine doses administered in the 12 months preceding that date. This is given per 100 people in the population. All doses, including boosters, are counted individually.

What share of the population has received at least one dose of vaccine?

The following chart shows the share of the total population that has received at least one dose of vaccine. This may not equal the share with a complete initial protocol if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

Total number of people who have received at least one dose of vaccine

The following chart shows the total number of people that have received at least one dose of the COVID-19 vaccine. This may not equal the number with a complete initial protocol if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

What share of the population has completed the initial vaccination protocol?

The following chart shows the share of the total population that has completed the initial vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

Total number of people who have completed the initial vaccination protocol

The following chart shows the total number of people that have completed the initial vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

How many vaccine booster doses have been administered?

The following charts show the number of booster doses administered. Booster doses are doses administered beyond those prescribed by the original vaccination protocol — for example, a third dose of Pfizer/BioNTech vaccine, or a second dose of Johnson & Johnson vaccine.

Vaccinations by age

The following charts provide data on the share of people that have been vaccinated against by age group. This is provided as three metrics: the share that has received at least one dose; the share that has completed the initial protocol; and the share that is only partially vaccinated.

This data is only available for countries that report the breakdown of doses administered by first and second doses by age.

Share that have received at least one dose by age

The following chart shows the share of the population in each age group that has received at least one dose. This metric includes those that are partly vaccinated or have completed the initial protocol.

Share that have completed the initial protocol by age

The following chart shows the share of the population in each age group that has completed the initial protocol.

Share that have received a booster dose by age

The following chart shows the share of the population in each age group that has received a booster dose.

Which vaccines have been administered in each country?

The following chart shows the cumulative number of doses administered, broken down by vaccine manufacturer. This is only available for a select number of countries that report the necessary data.

How many doses are administered daily?

Daily number of doses administered per 100 people

The following chart shows the daily number of doses administered per 100 people. This is shown as the rolling seven-day average. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

Daily number of doses administered

How many doses have been donated by each country?

These charts show the cumulative number of doses donated to the COVAX initiative by different countries, broken down by whether the donations have only been announced, actually donated, or delivered to the recipients. This is only available for a select number of countries for which the COVID-19 Task Force reports the necessary data.

The first chart shows the number of doses donated, while the next three charts show that number adjusted for:

  1. The population of the donating country;
  2. The GDP of the donating country;
  3. The number of doses administered by the donating country to its own population.

COVID-19 Vaccines Global Access (COVAX)

COVAX is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO). COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines.

Vaccination policies

This interactive chart maps government policies on COVID-19 vaccination. Note that only policies on the availability of vaccinations are tracked. It does not track the number of people who have been vaccinated.

Countries are grouped into six categories:

  • No availability
  • Availability for ONE of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for TWO of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for ALL of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for all three plus partial additional availability (select broad groups/ages)
  • Universal availability

Vaccination policy data is sourced from the Oxford Coronavirus Government Response Tracker

This data on vaccination policies is sourced from the Oxford Coronavirus Government Response Tracker (OxCGRT).

This resource is published by researchers at the Blavatnik School of Government at the University of Oxford: Thomas Hale, Anna Petherik, Beatriz Kira, Noam Angrist, Toby Phillips and Samuel Webster.

The tracker presents data collected from public sources by a team of over one hundred Oxford University students and staff from every part of the world.

The data presented here is taken directly from the OxCGRT project; we at Our World in Data don’t track policy responses ourselves and we don’t make additions to the tracker’s dataset.

These charts are regularly updated based on the latest version of the response tracker.

OxCGRT is an ongoing collation project of live data. If you see any inaccuracies in the underlying data, or for specific feedback on the analysis or another aspect of the project please contact OxCGRT team. See the tracker’s notes and guidance on data quality.

Attitudes to COVID-19 vaccination

The Imperial College London YouGov Covid-19 Behaviour Tracker Data Hub has gathered global insights on people’s behaviors in response to COVID-19 throughout the pandemic. This survey covers public behaviors and attitudes ranging from mask-wearing to self-isolation, social distancing, symptoms and testing.

Their dataset on attitudes to vaccination extended from January 2021 until March 2022. You can explore the change in attitudes across countries over time here:

Frequently-asked questions

Why do the figures displayed on this page look different from the ones published by my government?

In some cases, the vaccination figures on this page can look different from the ones reported by governments. Most often it is not because of the numerator (number of people vaccinated) but instead because of the denominator (number of people in the population). This usually happens for two main reasons:

  1. The official data reports the vaccination coverage in terms of the share of people vaccinated in the population eligible for vaccination (very often, among adults only). Our priority is to make our data comparable between countries — regardless of criteria for eligibility, which tend to vary across countries and across time. For this reason, we always use the total population of the country (i.e. people of all ages) as the denominator.
  2. The official data uses a different population estimate. The population estimates we use come from the United Nations World Population Prospects. We use this data for its reliability, its consistent methods, and because it makes our work much easier (see below for more information). In a few cases, we use other sources when the figures provided by the UN differ substantially from reliable and more recent national estimates.
What population data are the per-capita metrics based on?

The population estimates we use come from the United Nations World Population Prospects. We use this data for its reliability, its consistent methods, and because it makes our work much easier. The exact values can be viewed in our GitHub repository.

The United Nations estimates may not always reflect the latest censuses or national figures—but there are several reasons why we use this data over country-by-country national population estimates.

  • The UNWPP dataset is the standard in research. The main reason is that it uses a reliable and standardized methodology for all countries. For example, if we used individual country data, some may include overseas workers, expats, undocumented immigrants, etc. but others wouldn’t.
  • Using data from the UN allows us to get accurate population estimates for all territories in the world very easily. Finding and maintaining estimates based on national censuses would be very time-consuming for our small team, without bringing much additional value to our work.
  • Other reasons include the availability of yearly data (national censuses are only conducted every few years), and avoiding double-counting in cases of border disputes.

For all these reasons, the UN data is the best solution to bring accurate per-capita metrics to our COVID data. In a few cases, we use other sources when the figures provided by the UN differ substantially from reliable and more recent national estimates.

Can the value of per-capita metrics exceed 100%?

The population estimates we use to calculate per-capita metrics are all based on the last revision of the United Nations World Population Prospects. In a few cases, we use other sources when the figures provided by the UN differ substantially from reliable and more recent national estimates. Additionally, it’s important to bear in mind that in some territories, vaccination coverage may include non-residents (such as tourists and foreign workers). For these reasons, per-capita metrics may sometimes exceed 100%.

What is the definition of a complete initial protocol?

In our data, people with a complete initial protocol are those who have received all doses prescribed by their vaccination regimen (e.g. 2 doses for Pfizer/BioNTech, Moderna, Oxford/AstraZeneca, etc. and 1 dose for Johnson & Johnson, CanSino, etc.).

Some countries also allow for alternative definitions, such as having been infected with SARS-CoV-2 in the past and having received 1 dose of a two-dose regimen. We currently ignore these alternative definitions to preserve the common definition of a complete protocol, i.e. all doses required in the vaccine regimen. This allows for optimal comparability between countries.

What classification are the income groups based on?

The income groups we use come from the World Bank income classification. The exact list of countries can be viewed in our GitHub repository.

Why isn’t my country shown by default on a chart? How do you choose which countries are shown?

Due to the limited space on our charts and the number of countries in the world, unfortunately, we cannot show every country in the world by default. On each chart of this page, therefore we choose a default selection of countries based on a mix of criteria: mainly total population, but also the number of doses administered and share of the population vaccinated. These lists are updated about once a month.

Are participants in vaccine clinical trials included in your data?

We do not include participants in the vaccine arm of clinical trials, as this data is not available for many of the hundreds of trials currently taking place.

How do you report vaccinations performed in Israel and Palestine?

In our dataset and charts on COVID-19 vaccinations, we report vaccinations performed in Israel and Palestine separately.

The vaccination data is needed to understand how the pandemic is evolving. For this, it is key to bring together the vaccination data with data on COVID-19 cases and COVID-19 deaths. Global health institutions that report on the pandemic are reporting these metrics separately: 

  • The World Health Organization reports the measures for Israel separately from Palestine in its data.
  • Johns Hopkins University also reports Israel separately from Palestine in its data on cases & deaths of COVID-19, which has been used worldwide in the last year.

Reporting the data for Palestine and Israel separately also allows us to show their respective reported vaccination levels. It makes clear what the respective vaccination levels are, as reported by the Government of Israel and the Palestinian Ministry of Health.

Finally, our dataset on COVID-19 vaccinations is sourced from official data published by governments and ministries of health from countries around the world. This is also the case for Israel and Palestine. We show figures for Palestine and Israel separately, as they are reported separately by the Government of Israel and the Palestinian Ministry of Health

The Populations Division of the United Nations reports population figures for countries around the world, and we are relying on their latest data (from their 2019 revision) for countries around the world of. They report a population of 8,655,541 people for Israel and a population of 5,101,416 people for Palestine.

The resulting shares of people vaccinated in Israel and Palestine can be seen in our COVID-19 Data Explorer.

Source information country by country

You can download the full dataset alongside the detailed sources on GitHub.

Vaccination against COVID-19 has now started in 218 locations.

LocationSourceLast observation dateVaccines
AfghanistanWorld Health OrganizationDec. 31, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
AlbaniaWorld Health OrganizationSep. 10, 2023Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
AlgeriaWorld Health OrganizationSep. 4, 2022Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V
AndorraWorld Health OrganizationSep. 24, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
AngolaWorld Health OrganizationDec. 31, 2023Oxford/AstraZeneca
AnguillaWorld Health OrganizationMar. 17, 2023Oxford/AstraZeneca, Pfizer/BioNTech
Antigua and BarbudaMinistry of HealthSep. 16, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
ArgentinaMinistry of HealthJan. 27, 2024CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
ArmeniaWorld Health OrganizationOct. 1, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, Sputnik Light, Sputnik V
ArubaGovernment of ArubaMar. 12, 2024Pfizer/BioNTech
AustraliaGovernment of Australia via CovidBaseAUDec. 31, 2023Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
AustriaEuropean CDCJun. 30, 2023Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sanofi/GSK, Valneva
AzerbaijanGovernment of AzerbaijanAug. 28, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
BahamasPan American Health OrganizationMay. 12, 2023Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech
BahrainMinistry of HealthDec. 21, 2022CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
BangladeshDirectorate General of Health ServicesJul. 2, 2024Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
BarbadosMinistry of HealthDec. 29, 2023Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BelarusWorld Health OrganizationSep. 3, 2023KoviVac/Chumakov, Sinopharm/Beijing, Sputnik Light, Sputnik V
BelgiumSciensanoFeb. 11, 2024Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
BelizeWorld Health OrganizationMay. 12, 2023Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BeninMinistry of HealthDec. 18, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
BermudaPan American Health OrganizationJul. 8, 2022Oxford/AstraZeneca, Pfizer/BioNTech
BhutanWorld Health OrganizationOct. 30, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BoliviaMinistry of Health via https://www.boligrafica.com/Oct. 7, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
Bonaire Sint Eustatius and SabaWorld Health OrganizationSep. 1, 2021Moderna, Pfizer/BioNTech
Bosnia and HerzegovinaWorld Health OrganizationJan. 29, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
BotswanaAfrica Centres for Disease Control and PreventionDec. 31, 2023Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
BrazilState governments via coronavirusbra1.github.ioMar. 22, 2023Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
British Virgin IslandsWorld Health OrganizationSep. 16, 2022Johnson&Johnson, Oxford/AstraZeneca
BruneiWorld Health OrganizationJun. 30, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BulgariaMinistry of HealthJun. 29, 2024Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Burkina FasoWorld Health OrganizationJul. 23, 2023Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
BurundiWorld Health OrganizationDec. 31, 2023Johnson&Johnson, Sinopharm/Beijing
CambodiaWorld Health OrganizationDec. 31, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
CameroonWorld Health OrganizationOct. 15, 2023Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
CanadaOfficial data from provinces via covid19tracker.caJul. 24, 2024Johnson&Johnson, Medicago, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
Cape VerdeWorld Health OrganizationSep. 25, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
Cayman IslandsWorld Health OrganizationDec. 29, 2023Oxford/AstraZeneca, Pfizer/BioNTech
Central African RepublicAfrica Centres for Disease Control and PreventionSep. 3, 2023Covaxin, Oxford/AstraZeneca
ChadAfrica Centres for Disease Control and PreventionDec. 31, 2023Sinopharm/Beijing
ChileMinistry of Health, via Ministry of Science GitHub repositoryDec. 29, 2023CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
ChinaNational Health CommissionFeb. 9, 2023CanSino, IMBCAMS, KCONVAC, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, ZF2001
ColombiaWorld Health OrganizationDec. 29, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
ComorosWorld Health OrganizationOct. 2, 2022Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing
CongoAfrica Centres for Disease Control and PreventionJul. 31, 2022Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Cook IslandsSPC Public Health DivisionFeb. 13, 2023Pfizer/BioNTech
Costa RicaCosta Rican Social Security FundOct. 6, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Cote d'IvoireWorld Health OrganizationFeb. 19, 2023Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
CroatiaMinistry of HealthNov. 28, 2023Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
CubaMinistry of HealthApr. 12, 2024Abdala, Soberana Plus, Soberana02
CuracaoGovernment of CuracaoMay. 12, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CyprusMinistry of HealthFeb. 22, 2023Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
CzechiaMinistry of HealthJul. 31, 2024Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
Democratic Republic of CongoWorld Health OrganizationJun. 4, 2023Oxford/AstraZeneca
DenmarkStatens Serum InstituteSep. 29, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
DjiboutiWorld Health OrganizationOct. 8, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
DominicaPan American Health OrganizationOct. 7, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
Dominican RepublicMinistry of Public HealthDec. 28, 2023Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
EcuadorGovernment of Ecuador via EcuacovidMar. 31, 2023CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
EgyptWorld Health OrganizationMay. 21, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
El SalvadorMinistry of HealthOct. 2, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
EnglandGovernment of the United KingdomJul. 10, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Equatorial GuineaWorld Health OrganizationJul. 24, 2022Sinopharm/Beijing, Sinovac
EstoniaNational Health BoardAug. 12, 2024Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
EswatiniWorld Health OrganizationJun. 4, 2023Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech
EthiopiaWorld Health OrganizationMay. 28, 2023Covaxin, Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
Faeroe IslandsGovernment of the Faeroe IslandsFeb. 18, 2022Moderna, Pfizer/BioNTech
Falkland IslandsGovernment of the Falkland IslandsApr. 14, 2021Oxford/AstraZeneca
FijiSPC Public Health DivisionMay. 1, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
FinlandFinnish Institute for Health and WelfareJan. 9, 2024Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
FrancePublic Health FranceJul. 10, 2023Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sanofi/GSK
French PolynesiaSPC Public Health DivisionMay. 1, 2023Johnson&Johnson, Pfizer/BioNTech
GabonAfrica Centres for Disease Control and PreventionFeb. 5, 2023Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
GambiaAfrica Centres for Disease Control and PreventionMar. 19, 2023Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
GeorgiaNational Center for Disease Control and Public HealthOct. 13, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
GermanyRobert Koch InstitutApr. 7, 2023Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Valneva
GhanaWorld Health OrganizationJul. 2, 2023Oxford/AstraZeneca, Sputnik V
GibraltarGovernment of GibraltarDec. 16, 2022Oxford/AstraZeneca, Pfizer/BioNTech
GreeceMinistry of HealthJun. 26, 2024Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
GreenlandGovernment of GreenlandMar. 14, 2022Moderna
GrenadaWorld Health OrganizationMar. 17, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GuatemalaMinistry of HealthMay. 12, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
GuernseyGovernment of GuernseyDec. 19, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GuineaNational Health Security AgencySep. 24, 2023Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
Guinea-BissauWorld Health OrganizationOct. 15, 2023Oxford/AstraZeneca, Sinopharm/Beijing
GuyanaMinistry of HealthFeb. 17, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
HaitiWorld Health OrganizationDec. 29, 2023Johnson&Johnson, Moderna
HondurasWorld Health OrganizationAug. 11, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
Hong KongFood and Health BureauAug. 10, 2024Pfizer/BioNTech, Sinovac
HungaryGovernment of HungaryDec. 27, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
IcelandDirectorate of HealthMar. 29, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
IndiaGovernment of IndiaAug. 12, 2024Corbevax, Covaxin, Novavax, Oxford/AstraZeneca, Sputnik V
IndonesiaGovernment of IndonesiaNov. 23, 2023Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
IranWorld Health OrganizationNov. 26, 2023COVIran Barekat, CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Soberana02, Sputnik Light, Sputnik V
IraqWorld Health OrganizationJan. 2, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
IrelandHeath Service ExecutiveMay. 10, 2024Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
Isle of ManIsle of Man GovernmentJun. 23, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Israel (see FAQ)Government of IsraelMay. 4, 2023Moderna, Pfizer/BioNTech
ItalyExtraordinary commissioner for the Covid-19 emergencyNov. 16, 2023Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sanofi/GSK
JamaicaMinistry of HealthOct. 3, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JapanPrime Minister's OfficeMay. 7, 2023Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
JerseyGovernment of JerseyJan. 29, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JordanWorld Health OrganizationAug. 21, 2022CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
KazakhstanGovernment of KazakhstanApr. 30, 2023Pfizer/BioNTech, QazVac, Sinopharm/Beijing, Sinovac, Sputnik V
KenyaWorld Health OrganizationApr. 2, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
KiribatiSPC Public Health DivisionFeb. 20, 2023Oxford/AstraZeneca
KosovoMinistry of HealthFeb. 12, 2023Oxford/AstraZeneca, Pfizer/BioNTech
KuwaitWorld Health OrganizationNov. 26, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
KyrgyzstanMinistry of HealthSep. 8, 2023Sinopharm/Beijing, Sputnik V
LaosWorld Health OrganizationAug. 11, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
LatviaNational Health ServiceJul. 11, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
LebanonWorld Health OrganizationDec. 22, 2022CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
LesothoWorld Health OrganizationMar. 19, 2023Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
LiberiaWorld Health OrganizationDec. 11, 2022Oxford/AstraZeneca
LibyaWorld Health OrganizationJan. 16, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
LiechtensteinFederal Office of Public HealthJun. 7, 2023Johnson&Johnson, Moderna, Novavax, Pfizer/BioNTech
LithuaniaMinistry of HealthAug. 14, 2024Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
LuxembourgGovernment of LuxembourgJun. 11, 2023Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
MacaoGovernment of MacaoApr. 13, 2023Pfizer/BioNTech, Sinopharm/Beijing
MadagascarWorld Health OrganizationJul. 30, 2023Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
MalawiWorld Health OrganizationSep. 24, 2023Johnson&Johnson, Oxford/AstraZeneca
MalaysiaGovernment of MalaysiaAug. 14, 2024CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
MaldivesWorld Health OrganizationMay. 25, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
MaliWorld Health OrganizationMay. 14, 2023Oxford/AstraZeneca
MaltaCOVID-19 Malta Public Health Response TeamMar. 19, 2024Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MauritaniaAfrica Centres for Disease Control and PreventionNov. 19, 2023Oxford/AstraZeneca, Sinopharm/Beijing
MauritiusWorld Health OrganizationJul. 30, 2023Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing
MexicoWorld Health OrganizationNov. 18, 2022CanSino, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
MoldovaMinistry of HealthDec. 23, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
MonacoNational CouncilDec. 21, 2021Pfizer/BioNTech
MongoliaMinistry of Health via ikon.mnMay. 18, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MontenegroGovernment of MontenegroAug. 26, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MontserratWorld Health OrganizationDec. 16, 2022Oxford/AstraZeneca
MoroccoWorld Health OrganizationMay. 14, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
MozambiqueWorld Health OrganizationJul. 2, 2023Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
MyanmarWorld Health OrganizationAug. 21, 2023Oxford/AstraZeneca, Sinopharm/Beijing
NamibiaAfrica Centres for Disease Control and PreventionNov. 12, 2023Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
NauruWorld Health OrganizationFeb. 20, 2023Oxford/AstraZeneca
NepalWorld Health OrganizationNov. 23, 2023Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
NetherlandsEuropean CDC, via Marino van ZelstSep. 29, 2023Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
New CaledoniaSPC Public Health DivisionMay. 9, 2023Pfizer/BioNTech
New ZealandMinistry of HealthAug. 11, 2024Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
NicaraguaWorld Health OrganizationAug. 11, 2023Abdala, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Soberana02, Sputnik Light, Sputnik V
NigerWorld Health OrganizationJul. 30, 2023Oxford/AstraZeneca, Sinopharm/Beijing
NigeriaWorld Health OrganizationNov. 5, 2023Oxford/AstraZeneca
NiueSPC Public Health DivisionMar. 4, 2023Pfizer/BioNTech
North MacedoniaWorld Health OrganizationMay. 7, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, Sputnik V
Northern CyprusMinistry of HealthDec. 6, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
Northern IrelandGovernment of the United KingdomJul. 11, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
NorwayNorwegian Institute of Public HealthNov. 13, 2022Moderna, Pfizer/BioNTech
OmanWorld Health OrganizationOct. 25, 2022CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
PakistanNational Command and Operation CentreNov. 14, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
Palestine (see FAQ)World Health OrganizationOct. 18, 2022CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
PanamaPan American Health OrganizationMay. 12, 2023Oxford/AstraZeneca, Pfizer/BioNTech
Papua New GuineaSPC Public Health DivisionMay. 1, 2023Oxford/AstraZeneca
ParaguayPan American Health OrganizationMay. 12, 2023Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
PeruMinisterio de Salud via github.com/jmcastagnetto/covid-19-peru-vacunasDec. 10, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
PhilippinesDepartment of Health via ABS-CBN Investigative and Research GroupMar. 19, 2023Covaxin, Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
PitcairnSPC Public Health DivisionAug. 29, 2022Oxford/AstraZeneca
PolandMinistry of HealthNov. 10, 2023Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
PortugalWorld Health OrganizationSep. 29, 2023Covaxin, Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sanofi/GSK, Sinopharm/Beijing, Sinovac
QatarMinistry of Public HealthMay. 7, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
RomaniaGovernment of Romania via datelazi.roDec. 23, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
RussiaOfficial data from local governments via gogov.ruSep. 27, 2023EpiVacCorona, Sputnik V
RwandaWorld Health OrganizationJun. 4, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
Saint HelenaGovernment of Saint HelenaMay. 5, 2021Oxford/AstraZeneca
Saint Kitts and NevisPan American Health OrganizationDec. 7, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Saint LuciaMinistry of HealthDec. 2, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Saint Vincent and the GrenadinesWorld Health OrganizationApr. 21, 2023Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik Light, Sputnik V
SamoaSPC Public Health DivisionApr. 17, 2023Oxford/AstraZeneca
San MarinoWorld Health OrganizationMay. 22, 2022Pfizer/BioNTech, Sputnik V
Sao Tome and PrincipeWorld Health OrganizationJul. 30, 2023Oxford/AstraZeneca
Saudi ArabiaSaudi Health CouncilApr. 25, 2023Oxford/AstraZeneca, Pfizer/BioNTech
ScotlandGovernment of the United KingdomSep. 11, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SenegalWorld Health OrganizationNov. 12, 2023Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
SerbiaGovernment of SerbiaJun. 23, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
SeychellesWorld Health OrganizationApr. 9, 2023Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Sierra LeoneWorld Health OrganizationJul. 30, 2023Oxford/AstraZeneca, Sinopharm/Beijing
SingaporeGovernment of SingaporeJan. 31, 2023Moderna, Novavax, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
Sint Maarten (Dutch part)World Health OrganizationMar. 31, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SlovakiaMinistry of HealthJul. 31, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
SloveniaNational Institute of Public Health via covid-19.sledilnik.orgJul. 6, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
Solomon IslandsSPC Public Health DivisionOct. 31, 2022Oxford/AstraZeneca
SomaliaWorld Health OrganizationJul. 25, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
South AfricaMinistry of HealthSep. 24, 2023Johnson&Johnson, Pfizer/BioNTech
South KoreaKorea Centers for Disease Control and PreventionMay. 26, 2023Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
South SudanWorld Health OrganizationOct. 1, 2023Johnson&Johnson, Oxford/AstraZeneca
SpainMinistry of HealthMay. 24, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Sri LankaMinistry of Health's Epidemiology UnitOct. 30, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
SudanWorld Health OrganizationApr. 2, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
SurinameGovernment of SurinameMay. 23, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
SwedenPublic Health Agency of SwedenFeb. 26, 2024Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
SwitzerlandFederal Office of Public HealthJul. 3, 2023Johnson&Johnson, Moderna, Novavax, Pfizer/BioNTech
SyriaWorld Health OrganizationApr. 18, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
TaiwanTaiwan Centers for Disease ControlSep. 24, 2023Medigen, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
TajikistanWorld Health OrganizationDec. 23, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
TanzaniaWorld Health OrganizationMar. 12, 2023Johnson&Johnson, Pfizer/BioNTech, Sinopharm/Beijing
ThailandGovernment of ThailandSep. 30, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
TimorWorld Health OrganizationNov. 22, 2023Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
TogoWorld Health OrganizationNov. 19, 2023Oxford/AstraZeneca
TokelauSPC Public Health DivisionDec. 5, 2022Pfizer/BioNTech
TongaSPC Public Health DivisionApr. 11, 2023Oxford/AstraZeneca
Trinidad and TobagoMinistry of HealthSep. 21, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
TunisiaWorld Health OrganizationJun. 20, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
TurkeyCOVID-19 Vaccine Information PlatformNov. 22, 2022Pfizer/BioNTech, Sinovac, Turkovac
TurkmenistanWorld Health OrganizationAug. 6, 2023EpiVacCorona, Oxford/AstraZeneca, QazVac, Sinopharm/Beijing, Sputnik V, ZF2001
Turks and Caicos IslandsWorld Health OrganizationJan. 6, 2023Pfizer/BioNTech
TuvaluWorld Health OrganizationFeb. 1, 2023Oxford/AstraZeneca
UgandaWorld Health OrganizationMay. 28, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
UkraineMinistry of HealthDec. 23, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
United Arab EmiratesNational Emergency Crisis and Disaster Management AuthorityJun. 20, 2022CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
United KingdomGovernment of the United KingdomSep. 11, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
United StatesCenters for Disease Control and PreventionMay. 9, 2023Johnson&Johnson, Moderna, Novavax, Pfizer/BioNTech
UruguayMinistry of Health via vacuna.uyNov. 13, 2023Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
UzbekistanWorld Health OrganizationDec. 23, 2023Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik Light, Sputnik V, ZF2001
VanuatuSPC Public Health DivisionFeb. 20, 2023Oxford/AstraZeneca
VenezuelaPan American Health OrganizationDec. 7, 2022Abdala, Sinopharm/Beijing, Sinovac, Soberana02, Sputnik Light, Sputnik V
VietnamWorld Health OrganizationJun. 30, 2023Abdala, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
WalesGovernment of the United KingdomJun. 30, 2023Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Wallis and FutunaSPC Public Health DivisionJan. 23, 2023Moderna
YemenWorld Health OrganizationDec. 10, 2023CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
ZambiaGovernment of ZambiaJun. 25, 2023Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
ZimbabweMinistry of HealthOct. 9, 2022Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V

Sign up for regular updates from Our World in Data


→ If you want to keep up-to-date with our work on COVID-19, and the many other topics we cover you can sign up for our newsletter.